Sponsor or institution
Clinical trials and research at Tezcat Biosciences, INC.
As of November 12, 2026, Find a Trial lists 2 NIH-funded research projects at this institution, with $1.3 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2NIH research projects
NIH-funded research (2)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Tumor-targeted delivery of radio/chemotherapy for pancreatic cancer
A new treatment approach combines a targeted drug delivery system with a radioactive payload to attack pancreatic cancer cells that have mutant KRAS.
-
A new targeted drug for mutant KRas pancreatic cancer using a monobody delivery system
A small company is testing a novel antibody-like protein that can deliver a toxic drug to pancreatic cancers driven by mutant KRas, aiming to improve outcomes for patients with this hard-to-treat cancer.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.